|Publication Date||November 2010|
|Charts / Graphics||90 +|
Top Reasons to Read This Pharmaceutical Competitive Intelligence Report
Pharmaceutical competitive intelligence teams succeed when they’re visible, report to strategic planners and C-level executives and focus on pure CI-related activities. This study provides critical benchmarks to help your company.
Restructure the Competitive Intelligence Team for Success: Make sure your pharmaceutical competitive intelligence team does not stay buried in the organizational structure. Learn how to develop proper reporting lines and implement a more strategic organizational structure that will provide greater visibility and generate greater strategic impact.
Win Higher CI Budgets: Did you know that pharmaceutical competitive intelligence team budgets have gradually increased since 2007? Has yours? Learn why top-notch companies are funding competitive intelligence with greater investments year after year — and how they reap the benefits of their increasingly important teams.
Create a Competitive Intelligence Culture: Although competitive intelligence teams remain small, many companies do not rely solely on CI groups to do all the work. Learn how companies establish a culture of competitive intelligence to collect and share valuable information throughout the organization.
Key Questions That Are Answered About Pharmaceutical Competitive Intelligence
- How can competitive intelligence (CI) groups gain visibility and impact strategy with direct links to C-level executives and strategic planning initiatives?
- Can can CI teams overcome budget and staffing limitations?
- How can CI internal reputations be improved? How can successes and making measurable impact on decisions and strategies be communicated?